SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending sharply upwards following exceptionally positive Phase 2 S-OLARIS trial data for sonelokimab in axial spondyloarthritis, which revealed "disease-modifying" potential and robust efficacy. The community is buzzing with expectations for significant upside, fueled by a major institutional buyback, strong financials, and the upcoming Investor Day, intensifying talks of a potential short squeeze and a "best-in-class" valuation.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid fresh market uncertainty as new global tariffs announced by Trump following a Supreme Court ruling are sparking concerns over potential trade friction with allies like the EU and India. This sentiment is amplified by a significant pullback in Bitcoin, which some in the community see as a broader signal of financial system stress, with many actively debating whether the market will recover or face a deeper correction ahead of NVIDIA's crucial earnings report this week.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is seeing significant attention after reporting blowout earnings, strong guidance, and an ambitious capital expenditure outlook that reaffirms its central role in the AI supercycle, with investors also closely monitoring ongoing U.S.-Taiwan trade discussions that could further impact global chip supply.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is sparking intense debate following its earnings report, where the company announced a beta mortgage product and projected adjusted EBITDA profitability by Q2, electrifying bulls confident in its AI and capital-light transformation while bears remain skeptical of persistent losses and the iBuying model's viability amidst market volatility.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to a recent filing that would allow Trump's trust to sell a significant amount of stock and includes an evergreen provision for future share issuance, sparking active community discussion and widespread concerns over potential dilution and the company's long-term valuation.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as its Bysanti drug received FDA approval for bipolar I disorder and schizophrenia, notably gaining New Chemical Entity status and patent protection until 2044. The community is now keenly discussing the potential for a significant valuation re-rating, a short squeeze, and strong buyout interest from major pharma due to this and its promising GLP-1 nausea pipeline candidate.

BlackRock Institutional Trust Company N.A. - iShares China Large-Cap ETF

iShares China Large-Cap ETF

FXI is gaining attention as a U.S. court ruling blocking IEEPA levies signals a potential significant reduction in tariffs on Chinese goods, sparking community discussion about a broad trade truce. Many investors see this as a rare window for a rally in the often-oversold China market, even as questions persist regarding the nation's economic stability.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF ($EWY) is trending at all-time highs, propelled by strong performance from its major semiconductor holdings, Samsung and SK Hynix, amid surging demand for AI-driven memory and anticipated DRAM shortages through 2027. The community is actively discussing its remarkable outperformance compared to global markets and its continued growth potential.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is seeing significant conversation after a leadership change brought co-founder Aneel Bhusri back as CEO to spearhead its AI transformation, with recent earnings guidance and AI acquisitions sparking intense community debate over its growth prospects in a rapidly evolving SaaS landscape.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is a trending topic ahead of its earnings report, driven by expectations of strong AI server demand and recent analyst upgrades, although community discussion highlights skepticism and accusations of manipulation surrounding some downgrades amidst concerns about rising memory prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


OMRI
Omrix Biopharmaceuticals, Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest OMRI News

OMRIOmrix Biopharmaceuticals, Inc.